pubmed-article:12127554 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12127554 | lifeskim:mentions | umls-concept:C0024299 | lld:lifeskim |
pubmed-article:12127554 | lifeskim:mentions | umls-concept:C1551338 | lld:lifeskim |
pubmed-article:12127554 | lifeskim:mentions | umls-concept:C1292777 | lld:lifeskim |
pubmed-article:12127554 | lifeskim:mentions | umls-concept:C1332714 | lld:lifeskim |
pubmed-article:12127554 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
pubmed-article:12127554 | pubmed:issue | 9 | lld:pubmed |
pubmed-article:12127554 | pubmed:dateCreated | 2002-7-19 | lld:pubmed |
pubmed-article:12127554 | pubmed:abstractText | We report the findings of three new cases of a distinct clinicopathologic natural killer (NK) cell malignancy characterized by cutaneous, nodal and bone marrow infiltration by CD3-CD4+CD56+ NK blastic cells. Tumor cells were detected in bone marrow and in peripheral blood smears and showed finely distributed nuclear chromatin with nucleoli and a moderate amount of cytoplasm. Epstein-Barr virus (EBV) DNA was negative in the two tested cases. The immunophenotypes determined by flow cytometry were identical concerning mCD3-cytCD3-CD4+weakCD56+ HLA-DR+. The TCR was in germline configuration in the two cases tested. NK cell activity was demonstrated only in one out of the two cases tested. The negative reactions with alpha-naphthyl-acetate-esterase (ANAE), CD11b and CD14 strongly suggested that the tumor cells were not of the monocytic lineage. | lld:pubmed |
pubmed-article:12127554 | pubmed:language | eng | lld:pubmed |
pubmed-article:12127554 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12127554 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:12127554 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12127554 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12127554 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12127554 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12127554 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12127554 | pubmed:month | Sep | lld:pubmed |
pubmed-article:12127554 | pubmed:issn | 0145-2126 | lld:pubmed |
pubmed-article:12127554 | pubmed:author | pubmed-author:FossNorma TNT | lld:pubmed |
pubmed-article:12127554 | pubmed:author | pubmed-author:FalcãoRoberto... | lld:pubmed |
pubmed-article:12127554 | pubmed:author | pubmed-author:GarciaAglair... | lld:pubmed |
pubmed-article:12127554 | pubmed:author | pubmed-author:MarquesMaria... | lld:pubmed |
pubmed-article:12127554 | pubmed:author | pubmed-author:SimõesBelinda... | lld:pubmed |
pubmed-article:12127554 | pubmed:author | pubmed-author:FonsecaBenedi... | lld:pubmed |
pubmed-article:12127554 | pubmed:author | pubmed-author:RodriguesMiri... | lld:pubmed |
pubmed-article:12127554 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12127554 | pubmed:volume | 26 | lld:pubmed |
pubmed-article:12127554 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12127554 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12127554 | pubmed:pagination | 803-7 | lld:pubmed |
pubmed-article:12127554 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:12127554 | pubmed:meshHeading | pubmed-meshheading:12127554... | lld:pubmed |
pubmed-article:12127554 | pubmed:meshHeading | pubmed-meshheading:12127554... | lld:pubmed |
pubmed-article:12127554 | pubmed:meshHeading | pubmed-meshheading:12127554... | lld:pubmed |
pubmed-article:12127554 | pubmed:meshHeading | pubmed-meshheading:12127554... | lld:pubmed |
pubmed-article:12127554 | pubmed:meshHeading | pubmed-meshheading:12127554... | lld:pubmed |
pubmed-article:12127554 | pubmed:meshHeading | pubmed-meshheading:12127554... | lld:pubmed |
pubmed-article:12127554 | pubmed:meshHeading | pubmed-meshheading:12127554... | lld:pubmed |
pubmed-article:12127554 | pubmed:meshHeading | pubmed-meshheading:12127554... | lld:pubmed |
pubmed-article:12127554 | pubmed:meshHeading | pubmed-meshheading:12127554... | lld:pubmed |
pubmed-article:12127554 | pubmed:meshHeading | pubmed-meshheading:12127554... | lld:pubmed |
pubmed-article:12127554 | pubmed:meshHeading | pubmed-meshheading:12127554... | lld:pubmed |
pubmed-article:12127554 | pubmed:meshHeading | pubmed-meshheading:12127554... | lld:pubmed |
pubmed-article:12127554 | pubmed:meshHeading | pubmed-meshheading:12127554... | lld:pubmed |
pubmed-article:12127554 | pubmed:meshHeading | pubmed-meshheading:12127554... | lld:pubmed |
pubmed-article:12127554 | pubmed:meshHeading | pubmed-meshheading:12127554... | lld:pubmed |
pubmed-article:12127554 | pubmed:meshHeading | pubmed-meshheading:12127554... | lld:pubmed |
pubmed-article:12127554 | pubmed:meshHeading | pubmed-meshheading:12127554... | lld:pubmed |
pubmed-article:12127554 | pubmed:meshHeading | pubmed-meshheading:12127554... | lld:pubmed |
pubmed-article:12127554 | pubmed:meshHeading | pubmed-meshheading:12127554... | lld:pubmed |
pubmed-article:12127554 | pubmed:year | 2002 | lld:pubmed |
pubmed-article:12127554 | pubmed:articleTitle | Blastic CD4 NK cell leukemia/lymphoma: a distinct clinical entity. | lld:pubmed |
pubmed-article:12127554 | pubmed:affiliation | Department of Clinical Medicine, School of Medicine Ribeirão Preto-USP, Ribeirão Preto, SP, Brazil. rpfalcao@fmrp.usp.br | lld:pubmed |
pubmed-article:12127554 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:12127554 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |